Multiphoton microscopy and fluorescence lifetime imaging provide a novel method in studying drug distribution and metabolism in the rat liver in vivo.

Multiphoton microscopy has been shown to be a useful tool in studying drug distribution in biological tissues. In addition, fluorescence lifetime imaging provides information about the structure and dynamics of fluorophores based on their fluorescence lifetimes. Fluorescein, a commonly used fluorescent probe, is metabolized within liver cells to fluorescein mono-glucuronide, which is also fluorescent. Fluorescein and its glucuronide have similar excitation and emission spectra, but different fluorescence lifetimes. In this study, we employed multiphoton fluorescence lifetime imaging to study the distribution and metabolism of fluorescein and its metabolite in vivo in rat liver. Fluorescence lifetime values in vitro were used to interpret in vivo data. Our results show that the mean fluorescence lifetimes of fluorescein and its metabolite decrease over time after injection of fluorescein in three different regions of the liver. In conclusion, we have demonstrated a novel method to study a fluorescent compound and metabolite in vivo using multiphoton fluorescence lifetime imaging.

[1]  T. Gillbro,et al.  Resolution of ultrafast excited state kinetics of bilirubin in chloroform and bound to human serum albumin , 2004 .

[2]  M. Roberts,et al.  Structure-hepatic disposition relationships for cationic drugs in isolated perfused rat livers: transmembrane exchange and cytoplasmic binding process. , 2001, The Journal of pharmacology and experimental therapeutics.

[3]  William H. Sawyer,et al.  Spectral properties of the prototropic forms of fluorescein in aqueous solution , 1996, Journal of Fluorescence.

[4]  K. König,et al.  Non-invasive imaging of skin physiology and percutaneous penetration using fluorescence spectral and lifetime imaging with multiphoton and confocal microscopy. , 2011, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[5]  Hans Elmgren.  The fluorescence lifetime of free and conjugated fluorescein in various environments , 1980 .

[6]  Ignacy Gryczynski,et al.  Release of the self-quenching of fluorescence near silver metallic surfaces. , 2003, Analytical biochemistry.

[7]  Michael S Roberts,et al.  Cationic drug pharmacokinetics in diseased livers determined by fibrosis index, hepatic protein content, microsomal activity, and nature of drug. , 2002, The Journal of pharmacology and experimental therapeutics.

[8]  Wolfgang Becker,et al.  In vitro and in vivo imaging of xenobiotic transport in human skin and in the rat liver , 2008, Journal of biophotonics.

[9]  M. Roberts,et al.  Cytoplasmic binding and disposition kinetics of diclofenac in the isolated perfused rat liver , 2000, British journal of pharmacology.

[10]  M. Roberts,et al.  Effect of adjuvant-induced systemic inflammation in rats on hepatic disposition kinetics of taurocholate. , 2011, American journal of physiology. Gastrointestinal and liver physiology.

[11]  Sunwoo Park,et al.  Computational Strategies Unravel and Trace How Liver Disease Changes Hepatic Drug Disposition , 2009, Journal of Pharmacology and Experimental Therapeutics.

[12]  Chen-Yuan Dong,et al.  Visualization of hepatobiliary excretory function by intravital multiphoton microscopy. , 2007, Journal of biomedical optics.

[13]  T. Kagawa,et al.  Initial site of bile regurgitation following extrahepatic biliary obstruction in living rats , 2007, Journal of gastroenterology and hepatology.

[14]  N. Blair,et al.  Plasma fluorescein and fluorescein glucuronide in patients with selected eye diseases , 2005, Graefe's Archive for Clinical and Experimental Ophthalmology.

[15]  T. Tephly,et al.  THE GLUCURONIDATION OF OPIOIDS , OTHER XENOBIOTICS , AND ANDROGENS BY HUMAN UGT 2 B 7 Y ( 268 ) AND UGT 2 B 7 H ( 268 ) , 1998 .

[16]  Kenneth W. Dunn,et al.  Principles of Multiphoton Microscopy , 2006, Nephron Experimental Nephrology.

[17]  M. Roberts,et al.  Liver transporters in hepatic drug disposition: an update. , 2009, Current drug metabolism.

[18]  M. Roberts,et al.  Hepatic Pharmacokinetics of Cationic Drugs in a High-Fat Emulsion-Induced Rat Model of Nonalcoholic Steatohepatitis , 2011, Drug Metabolism and Disposition.

[19]  M. Roberts,et al.  An Improved Nonlinear Model Describing the Hepatic Pharmacokinetics of Digoxin: Evidence for Two Functionally Different Uptake Systems and Saturable Binding , 2010, Pharmaceutical Research.

[20]  V. de Giorgi,et al.  Nonlinear laser imaging of skin lesions , 2008, Journal of biophotonics.

[21]  M. Eftink,et al.  Fluorescence quenching studies with proteins. , 1981, Analytical biochemistry.

[22]  S. Nigam,et al.  Organic anion and cation transporter expression and function during embryonic kidney development and in organ culture models. , 2006, Kidney international.

[23]  P. Seybold,et al.  Solvent Dependence of the Fluorescence Lifetimes of Xanthene Dyes , 1999 .

[24]  M. Roberts,et al.  Liver fibrosis impairs hepatic pharmacokinetics of liver transplant drugs in the rat model. , 2010, Drug metabolism and pharmacokinetics.

[25]  T. Tephly,et al.  The glucuronidation of opioids, other xenobiotics, and androgens by human UGT2B7Y(268) and UGT2B7H(268). , 1998, Drug metabolism and disposition: the biological fate of chemicals.

[26]  Chen-Yuan Dong,et al.  In vivo dynamic metabolic imaging of obstructive cholestasis in mice. , 2009, American journal of physiology. Gastrointestinal and liver physiology.

[27]  Glen E. P. Ropella,et al.  Tracing Multiscale Mechanisms of Drug Disposition in Normal and Diseased Livers , 2010, Journal of Pharmacology and Experimental Therapeutics.

[28]  Y. Onganer,et al.  Fluorescence quenching of fluorescein with molecular oxygen in solution , 2005 .

[29]  R. Brubaker,et al.  Fluorescent, physiological and pharmacokinetic properties of fluorescein glucuronide. , 1985, Experimental eye research.

[30]  Glen E. P. Ropella,et al.  In silico representation of the liver-connecting function to anatomy, physiology and heterogeneous microenvironments , 2004, The 26th Annual International Conference of the IEEE Engineering in Medicine and Biology Society.

[31]  Michael S. Roberts,et al.  Physiologically Based Synthetic Models of Hepatic Disposition , 2006, Journal of Pharmacokinetics and Pharmacodynamics.

[32]  W. Webb,et al.  Multiphoton microscopy in biological research. , 2001, Current opinion in chemical biology.

[33]  G. Beddard,et al.  Excited state properties of bilirubin and its photoproducts using picosecond flourescence and ciruclarly polarized luminescence spectroscopy , 1981 .

[34]  G. H. Vickers,et al.  Use of time resolution to eliminate bilirubin interference in the determination of fluorescein. , 1986, Analytical chemistry.

[35]  Jens Eickhoff,et al.  In vivo multiphoton fluorescence lifetime imaging of protein-bound and free nicotinamide adenine dinucleotide in normal and precancerous epithelia. , 2007, Journal of biomedical optics.

[36]  I A Sherman,et al.  Hepatic transport of fluorescent molecules: In Vivo studies using intravital TV microscopy , 1986, Hepatology.

[37]  Glen E. P. Ropella,et al.  Modeling and Simulation of Hepatic Drug Disposition Using a Physiologically Based, Multi-agent In Silico Liver , 2008, Pharmaceutical Research.

[38]  A L GRAFFLIN,et al.  Studies of hepatic structure and function by fluorescence microscopy. , 1952, Bulletin of the Johns Hopkins Hospital.

[39]  Dietrich Schweitzer,et al.  Sodium fluorescein as a retinal pH indicator? , 2005, Physiological measurement.

[40]  A. Chorvatova,et al.  Multi-wavelength fluorescence lifetime spectroscopy: a new approach to the study of endogenous fluorescence in living cells and tissues , 2009 .

[41]  Raluca Niesner,et al.  Noniterative biexponential fluorescence lifetime imaging in the investigation of cellular metabolism by means of NAD(P)H autofluorescence. , 2004, Chemphyschem : a European journal of chemical physics and physical chemistry.

[42]  V HANZON,et al.  Liver cell secretion under normal and pathologic conditions studied by fluorescence microscopy on living rats. , 1952, Acta physiologica Scandinavica. Supplementum.

[43]  M. Larsen,et al.  Time-resolved fluorescence properties of fluorescein and fluorescein glucuronide. , 1989, Experimental eye research.

[44]  M. Neal,et al.  Metabolism of fluorescein after intravenous administration. , 1985, Investigative ophthalmology & visual science.

[45]  Chen-Yuan Dong,et al.  Optical biopsy of liver fibrosis by use of multiphoton microscopy. , 2004, Optics letters.

[46]  H. Hansen.  A pathologic-anatomical study on disc degeneration in dog, with special reference to the so-called enchondrosis intervertebralis. , 1952, Acta orthopaedica Scandinavica. Supplementum.